Skip to main content
. 2021 May 17;9(3):428–435. doi: 10.14218/JCTH.2020.00072

Table 1. Summary of factors associated with post-liver transplant NAFLD.

Increased risk Possible risk Possible protection
Obesity Sarcopenia Everolimus
T2DM CNI therapy
Hyperlipidemia Donor graft steatosis
PNPLA3 polymorphism
Corticosteroid therapy
Indications: NASH, ALD, HCV